Clinical trial
Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities.
NCT04818294 is registered in ClinicalTrials.gov with Elosan AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities.
- Lead sponsor
- Elosan AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 16, 2021
- Completion date
- June 15, 2022
- Enrollment
- 192 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.